BLFS - Company ID 0000834365
BIOLIFE SOLUTIONS INC trades as BLFS and has a market capitalization of $1.37 B, making it the #2428 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $96.21M, up 28.9% from the prior year and net income of -$4.59M. This page tracks BIOLIFE SOLUTIONS INC through 1,676 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 11 fiscal years BIOLIFE SOLUTIONS INC's revenue grew from $6.19M to $96.21M, a compound annual growth rate of 28.3%. Net profit margin expanded from -22.8% to -4.8% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13D/A | - | 2026-05-22 |
| Insider trade | 4 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
The largest companies sharing BIOLIFE SOLUTIONS INC's SEC industry classification (electromedical & electrotherapeutic apparatus).
BIOLIFE SOLUTIONS INC (BLFS) has a market capitalization of $1.37 B as of 2026-07-09, ranking #2428 among US-listed companies.
BIOLIFE SOLUTIONS INC reported revenue of $96.21M for fiscal year 2025, an increase of 28.9% year over year.
In its latest fiscal year BIOLIFE SOLUTIONS INC reported a net loss of $4.59M.